Patient Selection Brochure
4 Steps for Patient Selection
Please be informed that in some EU countries (Bulgaria, Cyprus, Estonia, France, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Poland, Portugal, Romania, Slovakia, Belgium , Netherlands, Slovenia and Spain) medical device advertisement to general public is not permitted. Therefore, if you are accessing this website from one of those countries and you are not a healthcare professional, you need to exit this site immediately, since you would be viewing information that may not be legally allowed under the laws of your country of residence. Should you disregard this warning notice, Boston Scientific declines any liability as to your access to such information. By clicking accept you confirm your understanding and acceptance of the statements of this disclaimer.
Hypertension is a global epidemic, affecting nearly a billion people worldwide1 and more than a quarter of all adults. This condition is a major risk factor for a variety of cardiovascular diseases, including coronary artery disease, heart failure, stroke and peripheral vascular disease. Hypertension accounts for an estimated 54 percent of all strokes and 47 percent of all ischemic heart disease globally2.
Most in the medical community agree that hypertension is multifactorial in nature and requires multiple therapeutic approaches targeting the underlying aspects of the disease. All major guidelines promote a combination of lifestyle modification and treatment with antihypertensive medications to reach target blood pressure levels. Although this approach works for many, it fails in a considerable number of patients for various reasons including drug-intolerance and non-compliance, leaving their blood pressure high and uncontrolled. It is estimated that 45% - 81% of patients with hypertension have uncontrolled hypertension3, leaving them at unacceptably high cardiovascular risk.